NCT06772818View on ClinicalTrials.gov

A Study to Evaluate the Effect of Food on Nemtabrutinib (MK-1026) in Healthy Participants (MK-1026-017)

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

October 2, 2023

Primary Completion Date

December 20, 2023

Study Completion Date

February 16, 2024

Conditions

Healthy

Interventions

DRUG

Nemtabrutinib

Oral Tablet

Trial Locations (1)

96813

Labcorp Clinical Research Unit Inc. (Site 0001), Honolulu

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY